van der Wall SJ, Lip GYH, Teutsch C, Kalejs O, Lyrer P, Hall C, Dubner SJ, Diener HC, Halperin JL, Ma CS, Rothman KJ, Zint K, Zhai D, Huisman MV, GLORIA-AF Investigators. Low bleeding and thromboembolic risk with continued dabigatran during cardiovascular interventions: the GLORIA-AF study. Eur J Intern Med. 2021 Sep;91:75-80. doi: 10.1016/j.ejim.2021.05.020
Navratil-Strawn J, Hartley S, MacLeod S, Lindsay A. The effect of a customized advocacy product on downstream medical expenditures and utilization. Telehealth and medicine today. 2021 Jan;6(2). doi: 10.30953/tmt.v6.250